CIBC Private Wealth Group
BSTC

CIBC Private Wealth Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History

CIBC Private Wealth Group’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,141
Closed -$219K – 1021
2020
Q3 		$219K Buy
+4,141
New +$256K ﹤0.01% 829
2020
Q2 		– Sell
-5,456
Closed -$309K – 857
2020
Q1 		$309K Sell
5,456
-1,147
-17% -$65.4K ﹤0.01% 709
2019
Q4 		$376K Sell
6,603
-67
-1% -$3.55K ﹤0.01% 755
2019
Q3 		$357K Sell
6,670
-669
-9% -$38.9K ﹤0.01% 750
2019
Q2 		$438K Sell
7,339
-1,400
-16% -$88.1K ﹤0.01% 733
2019
Q1 		$545K Buy
8,739
+134
+2% +$8.86K ﹤0.01% 709
2018
Q4 		$521K Sell
8,605
-345
-4% -$20.6K ﹤0.01% 672
2018
Q3 		$523K Sell
8,950
-280
-3% -$14.3K ﹤0.01% 769
2018
Q2 		$414K Sell
9,230
-1,135
-11% -$48.8K ﹤0.01% 812
2018
Q1 		$460K Sell
10,365
-1,230
-11% -$51.7K ﹤0.01% 798
2017
Q4 		$502K Buy
11,595
+110
+1% +$4.94K ﹤0.01% 781
2017
Q3 		$534K Buy
+11,485
New +$550K ﹤0.01% 763

Other funds holding BSTC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

CIBC Private Wealth Group's BSTC Position: Q4 2020 in Review

CIBC Private Wealth Group sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 4,141 shares — an estimated $219K sold.

CIBC Private Wealth Group first reported a position in BSTC in Q3 2017 and held it in 12 quarters. The position peaked at $545K in Q1 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

  • CIBC Private Wealth Group reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
  • CIBC Private Wealth Group sold 4,141 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $219K.
  • CIBC Private Wealth Group first reported a position in BioSpecifics Technologies Corp. in Q3 2017 and held it in 12 quarters.
  • CIBC Private Wealth Group's BioSpecifics Technologies Corp. position peaked at $545K in Q1 2019.
  • 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on CIBC Private Wealth Group's 13F filing for Q4 2020, filed 12 Feb 2021.